The Snowdome Foundation has partnered with Cure Cancer and Cancer Australia to fund a new novel myeloma research project.

The research will investigate a new diagnostic marker for treatment resistant myeloma. The team will investigate if treatment targeting this marker will improve response in those who do not respond to current treatments.

Dr Kate Vandyke from the University of Adelaide, South Australia Health and Medical Research Institute who will be leading the research commented:
‘New treatment options are desperately needed, and I believe with funding, we can improve the lives of myeloma patients with the poorest of outlooks. I am incredibly grateful to both Cure Cancer and the Snowdome Foundation for funding this work.’

Total project cost: $200,000
Snowdome contribution: $50,000
Funding gap: $50,000